Additionally, GRP78 has been observed on the cell surface of several human cancers, including prostate cancer, breast cancer, ovarian cancer, brain cancer, melanoma cancer, leukemia and lymphoma, where it functions as a signaling receptor [20,21,22,23,24]. This evidence concerns the gene HSPA5 and breast cancer.